These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Microbicides for the Treatment of Sexually Transmitted HIV Infections. Singh O; Garg T; Rath G; Goyal AK J Pharm (Cairo); 2014; 2014():352425. PubMed ID: 26556193 [TBL] [Abstract][Full Text] [Related]
24. Recommendations for the nonclinical development of topical microbicides for prevention of HIV transmission: an update. Lard-Whiteford SL; Matecka D; O'Rear JJ; Yuen IS; Litterst C; Reichelderfer P; J Acquir Immune Defic Syndr; 2004 May; 36(1):541-52. PubMed ID: 15097296 [TBL] [Abstract][Full Text] [Related]
25. Nanomedicine in the development of anti-HIV microbicides. das Neves J; Nunes R; Rodrigues F; Sarmento B Adv Drug Deliv Rev; 2016 Aug; 103():57-75. PubMed ID: 26829288 [TBL] [Abstract][Full Text] [Related]
27. Twice-daily application of HIV microbicides alter the vaginal microbiota. Ravel J; Gajer P; Fu L; Mauck CK; Koenig SS; Sakamoto J; Motsinger-Reif AA; Doncel GF; Zeichner SL mBio; 2012 Dec; 3(6):. PubMed ID: 23249810 [TBL] [Abstract][Full Text] [Related]
28. Development of topical microbicides for prevention of human immunodeficiency virus and herpes simplex virus. Keller MJ; Klotman ME; Herold BC Am J Reprod Immunol; 2003 May; 49(5):279-84. PubMed ID: 12854732 [TBL] [Abstract][Full Text] [Related]
29. Structure activity relationship of dendrimer microbicides with dual action antiviral activity. Tyssen D; Henderson SA; Johnson A; Sterjovski J; Moore K; La J; Zanin M; Sonza S; Karellas P; Giannis MP; Krippner G; Wesselingh S; McCarthy T; Gorry PR; Ramsland PA; Cone R; Paull JR; Lewis GR; Tachedjian G PLoS One; 2010 Aug; 5(8):e12309. PubMed ID: 20808791 [TBL] [Abstract][Full Text] [Related]
30. Microbicides and other topical agents in the prevention of HIV and sexually transmitted infections. Nikolic DS; Garcia E; Piguet V Expert Rev Anti Infect Ther; 2007 Feb; 5(1):77-88. PubMed ID: 17266456 [TBL] [Abstract][Full Text] [Related]
31. Female genital tract secretions and semen impact the development of microbicides for the prevention of HIV and other sexually transmitted infections. Herold BC; Mesquita PM; Madan RP; Keller MJ Am J Reprod Immunol; 2011 Mar; 65(3):325-33. PubMed ID: 21143689 [TBL] [Abstract][Full Text] [Related]
32. Boost for vaginal microbicides against HIV. Lange JM; Karam M; Piot P Lancet; 1993 Nov; 342(8883):1356. PubMed ID: 7901643 [TBL] [Abstract][Full Text] [Related]
33. Microbicides for the prevention of HIV infection in women: an overview of recent trials. Rosenberg ZF; Nel A; Heyward W; Mitchnick M Curr Opin HIV AIDS; 2006 Nov; 1(6):514-9. PubMed ID: 19372855 [TBL] [Abstract][Full Text] [Related]
34. The future of microbicides. Omar RF; Bergeron MG Int J Infect Dis; 2011 Oct; 15(10):e656-60. PubMed ID: 21705253 [TBL] [Abstract][Full Text] [Related]
35. Topical microbicides: missing link for HIV prevention. Heise L Sex Health Exch; 1999; (1):3-5. PubMed ID: 12295464 [TBL] [Abstract][Full Text] [Related]
36. The search for a topical dual action spermicide/microbicide. Hughes LM; Griffith R; Aitken RJ Curr Med Chem; 2007; 14(7):775-86. PubMed ID: 17346162 [TBL] [Abstract][Full Text] [Related]
37. Role of microbicides in the prevention of HIV and sexually transmitted diseases - a review. Ramachandran R; Shanmughavel P Curr HIV Res; 2009 May; 7(3):279-86. PubMed ID: 19442123 [TBL] [Abstract][Full Text] [Related]
38. Development of a comprehensive human immunodeficiency virus type 1 screening algorithm for discovery and preclinical testing of topical microbicides. Lackman-Smith C; Osterling C; Luckenbaugh K; Mankowski M; Snyder B; Lewis G; Paull J; Profy A; Ptak RG; Buckheit RW; Watson KM; Cummins JE; Sanders-Beer BE Antimicrob Agents Chemother; 2008 May; 52(5):1768-81. PubMed ID: 18316528 [TBL] [Abstract][Full Text] [Related]
39. Microbicides: a new frontier in HIV prevention. McGowan I Biologicals; 2006 Dec; 34(4):241-55. PubMed ID: 17097303 [TBL] [Abstract][Full Text] [Related]